Clinical Pharmacology and Pharmacy, VUMC, Amsterdam, The Netherlands
Pharmacy, Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria.
Eur J Hosp Pharm. 2023 Jul;30(4):227-231. doi: 10.1136/ejhpharm-2021-002763. Epub 2021 Jul 20.
As yet, there is no European data standard for naming and describing oncology regimens. To enable real-world cancer treatment data comparisons, the Oncology Data Network created a unified reference database for systemic anti-cancer regimens used in practice across Europe. Data are extracted from clinical systems and mapped to a single standard called the "Core Regimen Reference Library (CRRL)". An automated matching algorithm has been designed based on: drug combinations; administration schedule; and dosing and route of administration. Incomplete matches are flagged for expert review. The aim of this pilot study is to have an expert pharmacist panel test the algorithm's feasibility by comparing computerised and manual matching of regimens that are currently in use in different European countries.
The combined team pooled a diverse sample of 47 reference regimens used in Europe for solid and haematological cancers. These were then codified to the developed common data standard and the algorithm was used to match them to the CRRL. The expert pharmacist panel from the European Society of Oncology Pharmacy (ESOP) selected 12 regimens from the sample set, ranging from simple to complex, and performed a single-blind test of the algorithm, by systematically matching each original regimen to the CRRL.
ESOP validated the algorithm's feasibility based on full concurrence between manual and computer matches thereby validating the algorithm rules and logic with regard to what defines the core characteristics of a regimen and how to compare similarities and differences.
ESOP's validation of the matching algorithm and approach to curating a master library provides confidence in their utility for reliable comparison of real-world regimen usage across Europe.
目前,欧洲还没有用于命名和描述肿瘤治疗方案的标准。为了实现真实世界癌症治疗数据的比较,肿瘤学数据网络创建了一个统一的参考数据库,用于记录欧洲各地实际使用的全身抗肿瘤方案。数据从临床系统中提取,并映射到一个名为“核心方案参考库(CRRL)”的单一标准。根据药物组合、给药方案以及剂量和给药途径,设计了一种自动匹配算法。不完整的匹配项会被标记出来供专家审核。本试点研究的目的是让专家药剂师小组通过比较目前在不同欧洲国家使用的方案的计算机匹配和手动匹配,测试该算法的可行性。
联合团队汇集了欧洲用于实体瘤和血液系统癌症的 47 种不同参考方案。这些方案被编码到已开发的通用数据标准中,并使用算法将其与 CRRL 进行匹配。欧洲肿瘤药学学会(ESOP)的专家药剂师小组从样本集中选择了 12 种方案,范围从简单到复杂,并对算法进行了单次盲法测试,即系统地将每种原始方案与 CRRL 进行匹配。
ESOP 根据手动和计算机匹配的完全一致性验证了算法的可行性,从而验证了算法规则和逻辑,即确定方案核心特征的方法以及比较相似性和差异性的方法。
ESOP 对匹配算法和主库管理方法的验证为其在欧洲范围内可靠比较真实世界方案使用情况的实用性提供了信心。